Article: Kunming Pharma to establish new production base for antimalarial drug.

Kunming Pharma to establish new production base for antimalarial drug

Shanghai. February 27. INTERFAX-CHINA - Kunming Pharmaceutical Corp. Co.

Ltd.'s shareholders have approved the establishment of a new RMB 50 million ($6.45 million) production base for its antimalarial drug, the listed arm of the group announced today.

One of China's largest herbal medicine manufacturers, Kunming Pharma specializes in the production of ARCO, which is also known as compound complex naphthoquine phosphate tablets, made from arteannuin. According to the World Health Organization, arteanniun is the most effective treatment for malaria.

"Last year, the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!